MRNADVANCE

Live / Registered — Registered (as of 31 Dec 2024)

What this means for you

Registered since 31 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98211073
Registration number
7630312
Mark type
Stylized text
Filed
05 Oct 2023
Published for opposition
12 Nov 2024
Registered
31 Dec 2024
Attorney of record
Lisa C. Pavento

Goods and services

  • Class 005 — Pharmaceuticals: Reagents for medical use for measurement of HBs antibody; medicines consisting of RNA for treating cancer; crude medicines for treating ocular diseases; cellular function activating agents for medical purposes; colostral antibodies for veterinary purposes; chemico-pharmaceutical preparations for treating cancer; chemical preparations for use in DNA analysis for medical purposes; chemical preparations for use in RNA analysis for medical purposes; bacterial preparations for medical and veterinary use; chemical preparations for treating cancer for medical or veterinary purposes; biotechnological preparations for medical purposes, namely, reagents for medical purposes; biological reagents for medical purposes; biochemical preparations for medical purposes; reagents for medical use; bispecific colostral antibody for medical use; trace element preparations being dietary supplements for human use; clinical medical reagents; pharmaceutical preparations for the treatment of cancer; medical diagnostic reagents for the detection of mRNA antigens; colostral antibodies for medical purposes
  • Class 009 — Scientific and electric apparatus: DNA analysis apparatus, namely, medical laboratory research instruments for DNA analysis; DNA chips; RNA microarrays; cartridges for storing specimen used for RNA analysis apparatus, namely, solid phase extraction cartridges for laboratory use; reagent cartridges used for RNA analysis apparatus, namely, solid phase extraction cartridges for laboratory use; reagent containers used for RNA analysis apparatus, namely, solid phase extraction cartridges for laboratory use; RNA analysis apparatus, namely, medical laboratory research instruments for RNA analysis; RNA sequencing devices, namely, laboratory devices for detecting genetic sequences; RNA chips; genome analyzer machines, namely, laboratory devices for detecting genetic sequences and related downloadable computer operating software; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; bioreactors for cell culturing for scientific research; biochip analyzing apparatus for research or scientific purposes; biochip sensors for sensing antigens; biochips for research or scientific purposes; liquid dosage devices that measure the amounts to be dispensed, namely, dispensers for measuring and dispensing of distilled water, not for medical use; incubators for cell culture, not for medical purposes; cellchip inspectors being optical inspection apparatus; devices for analyzing protein sequence used as laboratory apparatus, namely, laboratory devices for detecting genetic sequences; physical and chemical machines for laboratory use; physical and chemical apparatus for analyzing genes, namely, laboratory devices for detecting genetic sequences; gene amplifiers being DNA microarrays; mRNA microarrays; RNA, MRNA, and DNA microarrays; nucleic acid sequencing devices and nucleic acid synthetic apparatus, namely, laboratory devices for detecting genetic sequences; diagnostic chips for inspecting blood plasma laboratory apparatus, namely, DNA chips; diagnostic chips for analyzing blood plasma laboratory apparatus, namely, DNA chips
  • Class 042 — Scientific and technological services: RNA technology research and development; providing temporary use of non-downloadable web application for sharing information in the RNA technology field; research in the field of RNA repair technology; research and development of RNA chips; research relating to science, namely, scientific research in the field of RNA; RNA screening for scientific research purposes; RNA sequence analysis for scientific research purposes; multiple nucleic acid analysis for scientific research purposes; molecular analysis for scientific research purposes; development of new technology for others in the field of biotechnology; biochemical analysis; drug discovery services; design of new products for others; pharmaceutical research and development; clinical studies of medicines, namely, conducting clinical trials for others; services for assessing the efficiency of pharmaceuticals, namely, product quality testing services; fusion protein analysis for scientific research purposes; computer programming services in the medical field; medical laboratories; management assistance services for medical image data, namely, engineering services; medicine research being medical research; analysis and evaluation of medical product development, namely, product quality testing services; providing scientific information on the testing, inspection and research of medical products; scientific and medical laboratory services relating to the production of bispecific antibody antibodies; pharmaceutical drug development for bispecific antibody; bispecific antibody research and development; evaluating of clinical trial progress, namely, conducting clinical trials for others; clinical trials, namely, conducting clinical trials for others; providing temporary use of online, non-downloadable computer operating software for genome analyzer machines

Owner

Prosecution history

  • 31 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 31 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
  • 12 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 12 Nov 2024 — PUBLISHED FOR OPPOSITION
  • 23 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 01 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 24 Sept 2024 — EXAMINER'S AMENDMENT ENTERED
  • 24 Sept 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 24 Sept 2024 — EXAMINERS AMENDMENT E-MAILED
  • 24 Sept 2024 — EXAMINERS AMENDMENT -WRITTEN
  • 13 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 13 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 13 Sept 2024 — ASSIGNED TO LIE
  • 26 Apr 2024 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
  • 08 Feb 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

View this trademark record on Marksy